ATE209505T1 - Ein intranasaler trivalenter rinderimpfstoff der modifiziertes lebendes ibrv, pi3v und brsv enhält - Google Patents

Ein intranasaler trivalenter rinderimpfstoff der modifiziertes lebendes ibrv, pi3v und brsv enhält

Info

Publication number
ATE209505T1
ATE209505T1 AT94119949T AT94119949T ATE209505T1 AT E209505 T1 ATE209505 T1 AT E209505T1 AT 94119949 T AT94119949 T AT 94119949T AT 94119949 T AT94119949 T AT 94119949T AT E209505 T1 ATE209505 T1 AT E209505T1
Authority
AT
Austria
Prior art keywords
pi3v
brsv
modified live
containing modified
vaccine containing
Prior art date
Application number
AT94119949T
Other languages
English (en)
Inventor
Daniel K Ciszewski
Michael J Mcginley
Connie S Phillips
Michael J Schnurr
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE209505T1 publication Critical patent/ATE209505T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94119949T 1993-12-29 1994-12-16 Ein intranasaler trivalenter rinderimpfstoff der modifiziertes lebendes ibrv, pi3v und brsv enhält ATE209505T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17509393A 1993-12-29 1993-12-29

Publications (1)

Publication Number Publication Date
ATE209505T1 true ATE209505T1 (de) 2001-12-15

Family

ID=22638852

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94119949T ATE209505T1 (de) 1993-12-29 1994-12-16 Ein intranasaler trivalenter rinderimpfstoff der modifiziertes lebendes ibrv, pi3v und brsv enhält

Country Status (8)

Country Link
EP (1) EP0661059B1 (de)
AT (1) ATE209505T1 (de)
AU (1) AU691842B2 (de)
CA (1) CA2136677A1 (de)
DE (1) DE69429238T2 (de)
DK (1) DK0661059T3 (de)
ES (1) ES2168284T3 (de)
ZA (1) ZA9410347B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751229B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT759780E (pt) * 1994-05-10 2001-01-31 American Home Prod Vacina melhorada de vsrb vivo modificado

Also Published As

Publication number Publication date
ZA9410347B (en) 1996-02-05
DE69429238T2 (de) 2002-06-13
CA2136677A1 (en) 1995-06-30
EP0661059B1 (de) 2001-11-28
AU8049794A (en) 1995-07-06
EP0661059A3 (de) 1996-07-03
EP0661059A2 (de) 1995-07-05
DE69429238D1 (de) 2002-01-10
ES2168284T3 (es) 2002-06-16
AU691842B2 (en) 1998-05-28
DK0661059T3 (da) 2002-03-18

Similar Documents

Publication Publication Date Title
GR3007158T3 (de)
PL296460A1 (en) Method of obtaining a trombine preparation effectively protected against viruses
ES8802616A1 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene 3'-azido-3'-desoxitimidina o uno de sus derivados farmaceuticamente aceptables.
NO20073151L (no) Fremgangsmater og sammensetninger for a behandle hepatitt C virus
DE69426051D1 (de) Infektiösen Bronchitis Virus 4/91 enthaltender Geflügel-Impfstoff
LU91597I2 (fr) Cominaison d'hémagglutinine filamenteuse et de pertactine (Infanrix hexa)
DK0835930T3 (da) Europæiske vaccinestammer af porcint reproduktions- og respirationssyndrom-virus. (PRRSV)
LU91314I2 (fr) "Combinaison de particules viroides de papillomavirus humain de type 6, 11, 16 et 18 (GARDASIL -GilGARD )"
DE3684255D1 (de) Thymidinkinase-deletionsmutanten von bovinem herpesvirus-1, diese enthaltende impfstoffe gegen bovine rhinotracheitis und verfahren zu deren herstellung und verwendung.
IE44911L (en) Rhinotracheitis vaccine.
GR3022755T3 (en) Chicken anaemia agent vaccine
ATE209505T1 (de) Ein intranasaler trivalenter rinderimpfstoff der modifiziertes lebendes ibrv, pi3v und brsv enhält
AU5034893A (en) A polyvalent live vaccine for infectious bovine rhinotracheitis virus infection, bovine viral diarrhea-mucosal disease virus infection, parainfluenza 3 virus infection, bovine RS virus infection and bovine adeno 7 virus infection
GR3007856T3 (de)
DE69921530D1 (de) Behandlung einer Virusinfektion bei Schweinen
AU3115189A (en) Live combination vaccine
FI903143A0 (fi) Menetelmä ihmisen nuhaviruksen serotyypittämiseksi
DE69428610D1 (de) Methoden zur kultivierung von infektiösem laryngotracheitis virus und von "egg-drop-syndrome" verursachendem virus
DE69215568D1 (de) Verfahren zur Hemmung der Sauerstofftoxizität in den Lungen
BR8706053A (pt) Processo para a preparacao de cepa mutante aperfeicoada de bordetella bronchiseptica,e vacina de germe atenuado ar produzida da mesma
GR861842B (en) Infectious bronchitis vaccines for a day-old chickens
FI893346A0 (fi) Icke-reverterande rna-virus.
EP0308724A3 (en) Treatment of human immunodeficiency virus using immunostimulating biologic

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification